Shares of HNI (HNI) have gained 8.8% over the past four weeks to close the last trading session at $47.26, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $69.50 indicates a potential upside of 47.1%.The average comprises four short-term price targets ranging from a low of $63 to a high of $80, with a standard deviation of $7.59. While the lowest estimate indicates an increase o ...

Group 1 - Contango ORE, Inc. (CTGO) closed at $20.27, with a 45.4% gain over the past four weeks, and a mean price target of $29.33 suggests a 44.7% upside potential [1] - The average price target ranges from a low of $26 to a high of $32, with a standard deviation of $3.06, indicating a potential increase of 28.3% to 57.9% from the current price [2] - Analysts show strong agreement on CTGO's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for CTGO's current year earnings has increased by 176.9% over the last 30 days, with no negative revisions [12] - CTGO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement, which appears to be a good guide for potential upside [13]

Core Viewpoint - Arcturus Therapeutics (ARCT) has seen a 7.5% increase in share price over the past four weeks, closing at $12.81, with analysts suggesting a potential upside of 371.4% based on a mean price target of $60.38 [1][12]. Price Targets and Analyst Estimates - The mean price target is derived from eight short-term estimates, with a standard deviation of $33.97, indicating variability among analysts [2]. - The lowest price target of $32 suggests a 149.8% increase, while the highest target of $140 indicates a potential surge of 992.9% [2]. - A low standard deviation among price targets suggests a strong consensus among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings estimates upward, which is a positive indicator for potential stock upside [4][11]. - The Zacks Consensus Estimate for the current year has increased by 42.1% over the past month, with four estimates rising and no negative revisions [12]. - ARCT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Caution on Price Targets - While price targets are a common metric for investors, relying solely on them can be misleading, as they often do not accurately predict stock price movements [3][7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8].

Arcosa (ACA) closed the last trading session at $86.33, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $109.20 indicates a 26.5% upside potential.The average comprises five short-term price targets ranging from a low of $100 to a high of $120, with a standard deviation of $7.29. While the lowest estimate indicates an increase of 15.8% from the current price level, the ...

Shares of Semtech (SMTC) have gained 9.4% over the past four weeks to close the last trading session at $37.33, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $56.33 indicates a potential upside of 50.9%.The average comprises 12 short-term price targets ranging from a low of $43 to a high of $68, with a standard deviation of $8.32. While the lowest estimate indicates an increas ...

Vertical Aerospace Ltd. (EVTL) closed the last trading session at $5.32, gaining 32% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.30 indicates a 93.6% upside potential.The average comprises five short-term price targets ranging from a low of $2 to a high of $15, with a standard deviation of $5.14. While the lowest estimate indicates a decline of 62.4% from the current price ...

European Wax Center, Inc. (EWCZ) closed the last trading session at $5.09, gaining 51.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $6.50 indicates a 27.7% upside potential.The average comprises eight short-term price targets ranging from a low of $4 to a high of $15, with a standard deviation of $3.51. While the lowest estimate indicates a decline of 21.4% from the current pr ...

Catalyst Pharmaceutical (CPRX) closed the last trading session at $24.96, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $34 indicates a 36.2% upside potential.The average comprises eight short-term price targets ranging from a low of $31 to a high of $40, with a standard deviation of $2.98. While the lowest estimate indicates an increase of 24.2% from the current pri ...

Backblaze, Inc. (BLZE) closed the last trading session at $5.70, gaining 25.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $10.83 indicates a 90% upside potential.The average comprises six short-term price targets ranging from a low of $8 to a high of $14, with a standard deviation of $1.94. While the lowest estimate indicates an increase of 40.4% from the current price level, ...

Shares of Oric Pharmaceuticals, Inc. (ORIC) have gained 44.1% over the past four weeks to close the last trading session at $8.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.90 indicates a potential upside of 131.3%.The average comprises 10 short-term price targets ranging from a low of $12 to a high of $25, with a standard deviation of $4.04. While the lowest estimate ...